What Does Verve Therapeutics Do?

Total employees299
HeadquartersCambridge
Founded2018

Verve Therapeutics is a clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering low-density lipoprotein cholesterol (LDL-C), a root cause of atherosclerotic cardiovascular disease (ASCVD). Verve is advancing its lead product candidate, VERVE-101, in clinical trials for patients with heterozygous familial hypercholesterolemia (HeFH).

Where Is Verve Therapeutics's Headquarters?

Verve Therapeutics officeVerve Therapeutics officeVerve Therapeutics officeVerve Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters serves as the central hub for Verve's research and development, clinical operations, corporate administration, and strategic decision-making, driving the innovation in gene editing therapies.

Notable Features:

Located within a modern life sciences campus, providing access to state-of-the-art laboratory and office facilities designed to support cutting-edge biotechnology research and development.

Work Culture:

Verve fosters a collaborative, innovative, and science-driven work culture. Employees are often mission-oriented, focused on tackling significant challenges in cardiovascular medicine with a sense of urgency and strong patient focus.

HQ Significance:

The Cambridge headquarters strategically positions Verve within one of the world's leading biotechnology ecosystems, facilitating access to top talent, renowned academic and research institutions, and industry collaborations.

Values Reflected in HQ: The headquarters' emphasis on advanced research facilities and its location within a dynamic innovation district underscore Verve's commitment to scientific excellence, cutting-edge technology, and developing transformative therapies for patients.

Location:

Verve Therapeutics is establishing a global presence primarily focused on advancing its clinical development programs. This includes conducting clinical trials in North America and Europe, engaging with international regulatory authorities like the FDA, EMA, and MHRA, and forming strategic collaborations with research institutions and pharmaceutical partners worldwide to accelerate the development and potential delivery of its gene editing medicines for cardiovascular disease to patients globally.

Street Address:

200 Cambridgepark Drive, Suite 4100

City:

Cambridge

State/Province:

Massachusetts

Country:

USA

Where Else Does Verve Therapeutics Operate Around the World?

London, United Kingdom

Address: c/o HMR, Cumberland Avenue, Park Royal, London, NW10 7EW, UK

Facilitates the execution of clinical studies for Verve's gene editing therapies in the UK and engagement with local regulatory bodies, playing a role in the company's global drug development strategy.

Buying Intent Signals for Verve Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Verve Therapeutics? Meet the Executive Team

As of April 2025, Verve Therapeutics' leadership includes:

Sekar Kathiresan, M.D. - Co-founder and Chief Executive Officer
Andrew Ashe, J.D., M.Sc. - Co-founder, President and Chief Operating Officer
Andrew Bellinger, M.D., Ph.D. - Chief Scientific Officer & Chief Medical Officer
Allison Dorval - Chief Financial Officer
Frederick G. Gassert - Chief Business Officer
Wendy Erler - Chief People Officer
Kristen Fortney, Ph.D. - Chief Technology Officer

Who's Investing in Verve Therapeutics?

Verve Therapeutics has been backed by several prominent investors over the years, including:

GV (Google Ventures)
ARCH Venture Partners
F-Prime Capital
Wellington Management
Casdin Capital
RA Capital Management
Blackstone Life Sciences
Novartis Institutes for BioMedical Research
Fidelity Management & Research Company
Biomatics Capital

What Leadership Changes Has Verve Therapeutics Seen Recently?

Hire3
Exits1

Over the past 12 months, Verve Therapeutics has significantly strengthened its executive leadership by appointing a new Chief Financial Officer, a new Chief Business Officer, and a new Chief Technology Officer. These changes reflect the company's strategic focus on advancing its clinical pipeline and preparing for future growth.

Departures

Jason Haddock, Jason Haddock resigned as Chief Financial Officer.

New Appointments:

Allison Dorval, Allison Dorval appointed as new Chief Financial Officer.
Frederick G. Gassert, Frederick G. Gassert appointed as new Chief Business Officer.
Kristen Fortney, Ph.D., Kristen Fortney, Ph.D., appointed as new Chief Technology Officer.

What Technology (Tech Stack) Is Used byVerve Therapeutics?

Discover the tools Verve Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Verve Therapeutics Email Formats and Examples

Verve Therapeutics commonly utilizes the email format combining the first initial and full last name of an employee. This is a standard approach for many companies in the biotechnology sector for professional communication.

[first_initial][last]@vervetx.com

Format

jdoe@vervetx.com

Example

85%

Success rate

What's the Latest News About Verve Therapeutics?

GlobeNewswire • May 9, 2024

Verve Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Progress

Verve Therapeutics announced its Q1 2024 financial results, offering updates on its gene editing pipeline, including VERVE-101, VERVE-102, and VERVE-201. The company emphasized its commitment to advancing clinical trials and research for cardiovascular disease treatments....more

Verve Therapeutics Press Release • May 7, 2024

Verve Therapeutics Presents New Preclinical Data on its VERVE-102 Program at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Verve shared new preclinical data for VERVE-102, an in vivo base editing medicine targeting the PCSK9 gene. The data, presented at ASGCT, showed robust and durable LDL-C lowering in non-human primates, supporting its potential as a treatment for ASCVD....more

Verve Therapeutics Press Release • February 20, 2024

Verve Therapeutics Appoints Kristen Fortney, Ph.D. as Chief Technology Officer

Verve Therapeutics announced Kristen Fortney, Ph.D., as its new Chief Technology Officer, effective March 4, 2024. Dr. Fortney brings deep expertise in bioinformatics, machine learning, and technology strategy to enhance Verve's gene editing platform capabilities....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Verve Therapeutics, are just a search away.